It is concluded that socially anxious individuals are characterized by interpretation biases when presented with threat-relevant information, and there is no evidence to suggest that they are characterized by memory biases for threat-relevant information.
The disease is characterized by memory loss and other cognitive deficits as well as the pathological hallmarks amyloid plaques and neurofibrillar tangles.
Activation of GSK-3β is presumed to be involved in various neurodegenerative diseases, including Alzheimer's disease (AD), which is characterized by memory disturbances during early stages of the disease.
It is characterized by memory deficit and progressive impairment of cognitive functions.
Dementia is characterized by memory loss, cognitive impairments and decline in intellectual performance.
Therefore, for people with aMCI who are characterized by memory impairment, neuropsychological assessments with high discriminative power for screening or detecting memory decline at a very early stage would be more practical and helpful.
AD is a severe neurodegenerative disease affecting more than 35 million people worldwide, and is characterized by memory impairment, neurofibrillary tangles formation and extracellular accumulation of Aβ42 in insoluble plaques.
Inflammation also contributes to chronic neurodegenerative diseases that are characterized by memory loss, including Alzheimer disease, Parkinson disease, multiple sclerosis, and even AIDS-related dementia (Di Filippo et al., 2008; Kipnis et al., 2008; Yirmiya and Goshen, 2011).
For example, AD is characterized by memory loss and cognitive impairment [ 2], PD can cause cognitive impairment, including dementia and behavioral changes [ 3], and HD is manifested with dementia, involuntary motor activity, personality changes and cognitive impairment [ 4].
Alzheimer's disease (AD) is one of the main causes of dementia among elderly individuals, and is characterized by memory impairments and loss of cognitive functions, which eventually leads to complete incapacity and death of patients within 3 9 years after diagnosis.
